FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors


+0 (0%)
Updated 05:30 01/01 IST

PARABDRUGS Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for PARABDRUGS
0% Bullish
0% Bearish

PARABDRUGS Buy or Sell - Brokerage Reports

No. of reports in last year
No. of analysts
Average Consensus Forecast
Consensus Potential
See PARABDRUGS Share Price Targets >>


Long term PARABDRUGS rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live PARABDRUGS message board: Is PARABDRUGS buy or sell? Should I buy PARABDRUGS shares? Why are PARABDRUGS shares falling? Should I invest in PARABDRUGS stock?

  1. Home

PARABDRUGS Share Price Discussion

No posts yet.
This service may be new or inactive. Please check back later.
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • PARABDRUGS - Share Price - Fundamentals

    Market Capitalization46.11
    Enterprise Value1,029.33
    Price to Earnings3.53
    Price to Book Value0.18
    Return on Capital Employed-0.41
    Return on Equity0.07
    Face Value10
    Dividend YieldNA
  • PARABDRUGS - Profit And Loss

    CONSOLIDATEDMar-18Mar-17 % Change
    Operating Profit-16-45.72-0.65
    Profit Before Tax-55-105.02-0.48
    Net Income-57-108.07-0.47
  • PARABDRUGS - Balance Sheet

    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds-872-815.330.07
    Total Liabilities1,2911,308.71-0.01
    Total Assets419493.38-0.15
  • PARABDRUGS - Cash Flow

    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity31.650.82
    Cash from Investing Activity10.51
    Cash from Financing Activity-4-2.190.83
    Net Cash FlowNA-0.03-1
  • PARABDRUGS - Ratios

    Return on Assets-0.14-0.22
    Return on Equity0.070.13
    Return on Capital Employed-0.41-0.58
  • PARABDRUGS - 3 year Growth

    3 Year CAGR Growth in Revenue-0.69
    3 Year CAGR Growth in Operating Profit0.8
    3 Year CAGR Growth in EBIDTA0.86
    3 Year CAGR Growth in Net Income0.85
    3 Yr CAGR Growth - Diluted EPS0.85
  • PARABDRUGS - 5 year Growth

    5 Year CAGR Growth in Revenue-0.91
    5 Year CAGR Growth in Operating Profit0.78
    5 Year CAGR Growth in EBIDTA0.84
    5 Year CAGR Growth in Net Income0.59
    3 Yr CAGR Growth - Diluted EPS0.59
  • PARABDRUGS - Related Communities

    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

FrontPage © 2020